DiaSorin Full Year 2024 Earnings: EPS: €3.37 (vs €2.87 in FY 2023)

Simply Wall St · 04/10/2025 04:15

DiaSorin (BIT:DIA) Full Year 2024 Results

Key Financial Results

  • Revenue: €1.19b (up 3.2% from FY 2023).
  • Net income: €188.1m (up 18% from FY 2023).
  • Profit margin: 16% (up from 14% in FY 2023).
  • EPS: €3.37 (up from €2.87 in FY 2023).
earnings-and-revenue-growth
BIT:DIA Earnings and Revenue Growth April 10th 2025

All figures shown in the chart above are for the trailing 12 month (TTM) period

DiaSorin Earnings Insights

Looking ahead, revenue is forecast to grow 7.4% p.a. on average during the next 3 years, compared to a 6.8% growth forecast for the Medical Equipment industry in Italy.

Performance of the Italian Medical Equipment industry.

The company's share price is broadly unchanged from a week ago.

Balance Sheet Analysis

While it's very important to consider the profit and loss statement, you can also learn a lot about a company by looking at its balance sheet. See our latest analysis on DiaSorin's balance sheet health.